JP2024542099A5 - - Google Patents
Info
- Publication number
- JP2024542099A5 JP2024542099A5 JP2024526594A JP2024526594A JP2024542099A5 JP 2024542099 A5 JP2024542099 A5 JP 2024542099A5 JP 2024526594 A JP2024526594 A JP 2024526594A JP 2024526594 A JP2024526594 A JP 2024526594A JP 2024542099 A5 JP2024542099 A5 JP 2024542099A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- mol
- composition according
- lipid
- section
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163275402P | 2021-11-03 | 2021-11-03 | |
| US63/275,402 | 2021-11-03 | ||
| PCT/US2022/079244 WO2023081776A1 (en) | 2021-11-03 | 2022-11-03 | Lipid formulations containing nucleic acids and methods of treatment for cystic fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542099A JP2024542099A (ja) | 2024-11-13 |
| JP2024542099A5 true JP2024542099A5 (https=) | 2025-11-12 |
Family
ID=86242208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526594A Pending JP2024542099A (ja) | 2021-11-03 | 2022-11-03 | 核酸を含む脂質調合物、及び嚢胞性線維症の治療方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230159449A1 (https=) |
| EP (1) | EP4426266A4 (https=) |
| JP (1) | JP2024542099A (https=) |
| AU (1) | AU2022381750A1 (https=) |
| CA (1) | CA3236675A1 (https=) |
| WO (1) | WO2023081776A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3176844A1 (en) * | 2020-05-01 | 2021-11-04 | Carlos G. PEREZ-GARCIA | Nucleic acids and methods of treatment for cystic fibrosis |
| CZ310613B6 (cs) | 2020-09-23 | 2026-01-28 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Lipidoidy pro transfekci nukleových kyselin a jejich použití |
| CZ310443B6 (cs) | 2021-07-19 | 2025-06-25 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití |
| CN117653606B (zh) * | 2023-11-14 | 2024-05-10 | 广东康百医药科技有限公司 | 一种间充质干细胞外泌体冻干保护剂及其应用 |
| WO2025111297A1 (en) * | 2023-11-21 | 2025-05-30 | Modernatx, Inc. | Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis |
| WO2025166325A1 (en) | 2024-02-02 | 2025-08-07 | Editas Medicine, Inc. | MODIFIED GUIDE RNAs |
| WO2025213138A1 (en) | 2024-04-05 | 2025-10-09 | Editas Medicine, Inc. | Crispr/rna-guided nuclease related methods and compositions for treating primary open angle glaucoma |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019013752A (es) * | 2017-05-16 | 2020-07-20 | Translate Bio Inc | Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr optimizado en codones. |
| ES3039647T3 (en) * | 2017-05-31 | 2025-10-23 | Arcturus Therapeutics Inc | Synthesis and structure of high potency rna therapeutics |
| WO2019191780A1 (en) * | 2018-03-30 | 2019-10-03 | Arcturus Therapeutics, Inc. | Lipid particles for nucleic acid delivery |
| KR20210091120A (ko) * | 2018-08-29 | 2021-07-21 | 트랜슬레이트 바이오 인코포레이티드 | Mrna-로딩된 지질 나노입자를 제조하는 개선된 공정 |
| AU2021236068A1 (en) * | 2020-03-09 | 2022-10-06 | Arcturus Therapeutics, Inc. | Compositions and methods for inducing immune responses |
-
2022
- 2022-11-03 AU AU2022381750A patent/AU2022381750A1/en active Pending
- 2022-11-03 JP JP2024526594A patent/JP2024542099A/ja active Pending
- 2022-11-03 EP EP22891055.0A patent/EP4426266A4/en active Pending
- 2022-11-03 CA CA3236675A patent/CA3236675A1/en active Pending
- 2022-11-03 US US18/052,505 patent/US20230159449A1/en active Pending
- 2022-11-03 WO PCT/US2022/079244 patent/WO2023081776A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024542099A5 (https=) | ||
| JP2023524071A5 (https=) | ||
| CN101291653B (zh) | 脂质包封的干扰rna | |
| ES2865699T3 (es) | Formulaciones de lípidos para la administración de ARN mensajero | |
| JP2023517644A5 (https=) | ||
| CN105658242A (zh) | 用于苯丙酮尿症的mrna疗法 | |
| JP2018529738A (ja) | メッセンジャーリボ核酸薬物の治療投与のための方法 | |
| US20030096774A1 (en) | Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same | |
| JP2024527940A5 (https=) | ||
| WO2025218536A1 (zh) | 靶向肺部高效递送核酸的脂质纳米颗粒、吸入式制剂及应用 | |
| IL302065A (en) | PAN-RAS mRNA CANCER VACCINES | |
| CA2203843C (en) | Liposome-encapsulated poly iclc | |
| WO2022147039A1 (en) | Compositions and methods for delivery of rna | |
| CN115708818A (zh) | 一种用于雾化吸入脂质纳米粒的通用型处方 | |
| Oku et al. | Evaluation of drug targeting strategies and liposomal trafficking. | |
| CN118766874A (zh) | 一种吸入式制剂、迭代优化流程及其应用 | |
| EP4003397B1 (en) | Treatment of cystic fibrosis by delivery of nebulized mrna encoding cftr | |
| WO2004078121A2 (en) | Liposome composition for reduction of liposome-induced complement activation | |
| KR20220149400A (ko) | 이황화 결합을 갖는 양이온성 지질을 사용하여 약물을 전달하기 위한 나노입자 조성물 및 그 제조방법 | |
| EP4678177A1 (en) | Arenavirus vaccine | |
| AU2023274159A1 (en) | COMPOSITION FOR IN-VIVO DELIVERING mRNA CONTAINING MODIFIED NUCLEOTIDE | |
| WO2023169506A1 (zh) | 编码新型冠状病毒S蛋白的mRNA疫苗 | |
| US20250144237A1 (en) | Agents, compositions and methods for enhanced delivery of nucleic acids to the cells within the respiratory system | |
| US20120121689A1 (en) | Small interfering rna delivery | |
| Monisha et al. | Liposomes as targeted drug delivery system: A review. |